Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
CircRUNX2 through has-miR-203 regulates RUNX2 to prevent osteoporosis
Qudong Yin1, Jian Wang1, Qiang Fu2
1Department of Orthopaedics, Wuxi No. 9 People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu, China.
Objective:
We aimed to discover the molecular mechanism of hsa_circ_0076694 (circRUNX2) on osteogenic differentiation. We also explored the interaction between circRUNX2, miR-203 and RUNX2.
Methods:
Clinical samples obtained from femoral neck fracture patients' bone tissues were used to collect circRUNX2, miR-203, and RUNX2 expression data, while their expression changes were observed in human bone mesenchymal stem cells (hBMSCs) during osteogenic differentiation. QRT-PCR and Western blot were used to analyse levels of RNAs and proteins. Biotin pull down, RIP, RNA FISH, and Dual-Luciferase Reporter assays demonstrated the relationship between circRUNX2, miR-203, and RUNX2. ALP and ARS staining were used to measure the degree of osteogenic differentiation under the control of circRUNX2, miR-203.
Results:
CircRUNX2 were down-regulated in osteoporotic patients' bone tissues. CircRUNX2 could inhibit miR-203 expression by sponging miR-203. MiR-203 inhibited osteogenic differentiation by targeting the 3'-UTR of RUNX2 and down-regulate RUNX2 expression. Overexpression of circRUNX2 promoted the expression of osteogenic differentiation-related proteins such as RUNX2, OCN, OPN, BSP, and prevented osteoporosis.
Conclusion:
circRUNX2 could sponge miR-203 and enhance RUNX2 expression, thus circRUNX2 prevents osteoporosis and may provide a novel therapeutic strategy for it.
Insights
Circular RNA circRUNX2 inhibits miR-203, enhancing RUNX2 expression and promoting osteogenic differentiation. This finding suggests circRUNX2 as a potential therapeutic target for preventing osteoporosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoporosis is a significant skeletal disorder characterized by decreased bone density and increased fracture risk.
- Understanding the molecular mechanisms regulating osteogenic differentiation is crucial for developing effective osteoporosis treatments.
Purpose of the Study:
- To elucidate the molecular mechanism of circRUNX2 in osteogenic differentiation.
- To investigate the regulatory interactions between circRUNX2, miR-203, and RUNX2 in bone metabolism.
Main Methods:
- Expression analysis of circRUNX2, miR-203, and RUNX2 in clinical samples and human bone mesenchymal stem cells (hBMSCs).
- Quantitative real-time PCR (qRT-PCR) and Western blotting to assess RNA and protein levels.
- Biotin pull-down, RNA immunoprecipitation (RIP), RNA fluorescence in situ hybridization (FISH), and Dual-Luciferase Reporter assays to determine molecular interactions.
- Alkaline phosphatase (ALP) and Alizarin Red S (ARS) staining to evaluate osteogenic differentiation.
Main Results:
- CircRUNX2 expression was found to be downregulated in bone tissues of osteoporotic patients.
- CircRUNX2 acts as a molecular sponge for miR-203, inhibiting its expression.
- MiR-203 targets the 3'-untranslated region (3'-UTR) of RUNX2, downregulating its expression and inhibiting osteogenic differentiation.
- Overexpression of circRUNX2 promoted osteogenic differentiation markers (RUNX2, OCN, OPN, BSP) and prevented osteoporosis.
Conclusions:
- CircRUNX2 sponges miR-203, leading to enhanced RUNX2 expression and promoting osteogenic differentiation.
- CircRUNX2 plays a protective role against osteoporosis.
- CircRUNX2 represents a potential novel therapeutic target for osteoporosis treatment.
More Related Videos
Related Concept Videos
Epigenetic Regulation
Cancer Prevention
Some...
Negative Regulator Molecules
GTPases and their Regulation
Large G-proteins,...
Cooperative Binding of Transcription Regulators
Prevention of Further Absorption of Poison

